1 (855) 322-2600

FIRST TIME CALLERS: 1 (813) 384-4000
2c-b Minimize


2cb, also known with its street names of 7th heaven, 7-up, Blue Mystic, Lucky 7 and Tripstasy, is a psychedelic drug which affects a person’s cognition and perception of reality. Its chemical makeup is 4-bromo-2, 5-dimethoxyphenethylamine and is included in the 2C family, a group of hallucinogenic drugs. 2cb usually takes the form of white powder which can be intake orally or inhaled but can also be sold as tablets or gel caps.

2cb Medical And Miscellaneous Uses

2cb was effective for this use because of minimal and short duration of side effects. It has also become a popular drug to induce aphrodisiac effects. Legally, a prescription from a certified health care practitioner such as doctors is needed to acquire and buy 2cb.

2cb Effects

The onset of effects of 2cb is comparatively fast in a span of 20 to 90 minutes after being ingested or smoked. It will peak after 15 to 30 minutes of ingestion or inhalation. The next stage called plateau will usually last for 2 to 3 hours which is influenced by the dosage of the drug.

"List of psychotropic substances under international control" (PDF). Archived from the original on 2 March 2007. http://www.incb.org/pdf/e/list/green.pdf. Retrieved 2007-03-30.  

 2^  "2C-B (Nexus) Reappears on the Club Drug Scene" (Press release). Drug Enforcement Administration. May 2001. Archived from the original on 5 October 2006. http://www.usdoj.gov/ndic/pubs0/665/index.htm. Retrieved 2006-10-04.

 3^  "Erowid 2C-B Vault : Dose/Dosage". http://www.erowid.org/chemicals/2cb/2cb_dose.shtml.

 4^  Ambrose JB, Bennett HD, Lee HS, Josephson SA (May 2010). "Cerebral vasculopathy after 4-bromo-2,5-dimethoxyphenethylamine ingestion". The Neurologist 16 (3): 199–202. doi:10.1097/NRL.0b013e3181a3cb53. PMID 20445431.

 5^  Bronson ME, Jiang W, DeRuiter J, Clark CR (1995). "A behavioral comparison of Nexus, cathinone, BDB, and MDA". Pharmacol. Biochem. Behav. 51 (2–3): 473–5. doi:10.1016/0091-3057(95)00013-M. PMID 7667371.

 6^  Carmo H, Hengstler JG, de Boer D, et al (January 2005). "Metabolic pathways of 4-bromo-2,5-dimethoxyphenethylamine (2C-B): analysis of phase I metabolism with hepatocytes of six species including human". Toxicology 206 (1): 75–89. doi:10.1016/j.tox.2004.07.004. PMID 15590110. http://linkinghub.elsevier.com/retrieve/pii/S0300-483X(04)00396-8.